Dermatology · Temple, TX
NPI
1033395074
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
409 W Adams Ave
Temple, TX, 76501
Phone (254) 742-3775
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
13,653 services
Medicare patients, 2024
1,704
Average age 76
Drug cost, 2024
$1.1M
5,038 prescriptions
Company payments, 2025
$1,606
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark G Tusa was code 99213 (office e&m - established), 2,730 times for 1,417 patients. In total Mark G Tusa billed 13,653 services in 112 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,730 | 1,417 | $58.47 | $160K |
| Q4197 Puraply xt, per square centimeter | Office | 1,799 | 28 | $81.20 | $146K |
| 17003 Destruction Skin Lesion | Office | 1,769 | 326 | $4.47 | $7,916 |
| 88305 Surgical Pathology Examination | Office | 1,296 | 576 | $23.89 | $31K |
| 17110 Destruction Skin Lesion | Office | 760 | 590 | $67.61 | $51K |
| 17000 Destruction Skin Lesion | Office | 654 | 471 | $30.70 | $20K |
| 11102 Skin Biopsy | Office | 652 | 496 | $52.02 | $34K |
| 17311 Mohs Surgery | Office | 376 | 308 | $460.76 | $173K |
| Q4194 Novachor, per square centimeter | Office | 307 | 15 | $761.33 | $234K |
| 11103 Skin Biopsy | Office | 296 | 156 | $35.79 | $11K |
| 17312 Mohs Surgery | Office | 184 | 132 | $295.55 | $54K |
| 36415 Venipuncture Blood Collection | Office | 181 | 129 | $2.96 | $536 |
| 11606 Skin Lesion Excision | Office | 168 | 126 | $288.87 | $49K |
| 12032 Wound Repair - All Levels | Office | 164 | 151 | $121.98 | $20K |
| 13132 Wound Repair - All Levels | Office | 164 | 139 | $171.56 | $28K |
By year: 2022 $919K for 11,700 services; 2023 $1.1M for 12,984 services; 2024 $1.4M for 13,653 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,296 | 576 | $23.89 | $31K |
| 36415 Venipuncture Blood Collection | 181 | 129 | $2.96 | $536 |
| 88312 Surgical Pathology Examination | 142 | 88 | $59.30 | $8,421 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark G Tusa prescribed most often to Medicare patients was Doxycycline Hyclate, with 781 prescriptions and refills. In total Mark G Tusa wrote 5,038 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 781 | 1,012 | 546 | $24K |
| Fluorouracil Generic | 573 | 731 | 401 | $45K |
| Triamcinolone Acetonide Generic | 501 | 616 | 302 | $6,451 |
| Clobetasol Propionate Generic | 411 | 421 | 218 | $20K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 324 | 324 | 268 | $1,400 |
| Ketoconazole Generic | 272 | 317 | 144 | $5,114 |
| Fluconazole Generic | 188 | 396 | 75 | $2,169 |
| Imiquimod Generic | 175 | 310 | 100 | $7,554 |
| Gabapentin Generic | 156 | 271 | 64 | $3,799 |
| Dutasteride Generic | 127 | 350 | 50 | $5,391 |
| Cephalexin Generic | 108 | 110 | 81 | $179 |
| Minoxidil Generic | 85 | 234 | 34 | $939 |
| Clindamycin Hcl Generic | 81 | 89 | 66 | $378 |
| Acyclovir Generic | 70 | 136 | 43 | $2,070 |
| Amoxicillin Generic | 53 | 114 | 30 | $638 |
Brand drugs: 191 claims; generic drugs: 4,847 claims; opioid claims: 342.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark G Tusa $1,606 ($1,606 in general payments such as food, travel and fees) from 22 companies. The largest payer was PolyMedics Innovations Inc. with $327.
| Company | Payments | Amount |
|---|---|---|
| PolyMedics Innovations Inc. | 1 | $327 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $213 |
| LEO Pharma Inc. | 12 | $185 |
| Organogenesis Inc. ORGO | 7 | $146 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $110 |
| Amgen Inc. AMGN | 5 | $76.97 |
| Abbvie Inc. ABBV | 4 | $70.69 |
| UCB, Inc. UCB.BR | 3 | $69.52 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $63.32 |
| Smith+Nephew, Inc. SNN | 2 | $62.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.